TrialBMC neurology2017

Long-term efficacy and safety of fingolimod in Japanese patients with relapsing multiple sclerosis: 3-year results of the phase 2 extension study.

Takahiko Saida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.